4 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
Follow Encephalomyelitis: new trials by email Literature Review of Encephalomyelitis trials Research Report on Encephalomyelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation Pregabalin, Independent walking training, Placebo - Chronic Fatigue Syndrome, COVID-19, Long Haul | Phase 2 | Terminated | National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland | 23 | 2023-10-24 | 2026-06-17 |
| Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome Etanercept - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis | Phase 2 | Terminated | Haukeland University Hospital | 4 | 2012-10-01 | 2015-12-02 |
| Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome Droxidopa - Chronic Fatigue Syndrome, Orthostatic Hypotension | Phase 2 | Terminated | Chelsea Therapeutics | 3 | 2010-07-01 | 2014-06-09 |
| B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome Rituximab - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis | Phase 2 | Terminated | Haukeland University Hospital | 8 | 2010-06-01 | 2024-03-04 |
Fatigue Syndrome, Chronic (4) · Hypotension, Orthostatic (1) · Post-Acute COVID-19 Syndrome (1)
Chronic Disease (4) · Disease Attributes (4) · Muscular Diseases (4) · Musculoskeletal Diseases (4) · Nervous System Diseases (4) · Neuroinflammatory Diseases (4) · Neuromuscular Diseases (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Autonomic Nervous System Diseases (1) · COVID-19 (1) · Cardiovascular Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1)
3,4-dihydroxyphenylserine aldolase (1) · Droxidopa (1) · Etanercept (1) · Pregabalin (1) · Psychotherapy (1) · Rituximab (1) · Telerehabilitation (1)
Haukeland University Hospital (2) · Chelsea Therapeutics (1) · National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland (1)
Norway (2) · Poland (1) · United States (1)
Beata Tarnacka, Prof, Md, PhD (1) · Charles W Lapp, M.D. (1) · Olav Mella, PhD, MD (1)